[1] Jemal A,Center MM,Desantis C,et al.Global patterns of cancer incidence and mortality rates and trends[J].Cancer Epidemiol Biomarkers Prev,2010,19(8):1893-1907.[2] Houghton AM. Mechanistic links between COPD and lung cancer[J]. Nat Rev Cancer, 2013,13(4):233-245.[3] Naess H,Nyland H,Idicula T,et al.C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients[J].Stroke Cerebrovasc Dis,2013,22(8):e435-440.[4] Alsulaimani S,Gardener H,Elkind MS,et al. Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study[J].Stroke,2013,44(2):457-461.[5] Orluwene CG,Mommoh MO. Plasma total homocysteine,high-senitivity C-reactive protein and thyroid function in metabolic sydrome patients[J]. Niger Postgrad Med J,2013,20(4):286-290.[6] Petras M,Tatarkova Z,Mokra D,et al. Hyperhomocysteinemia as a risk factor for the neuronal system disorders[J].J Physiol Pharmacol,2014,65(1):15-23.[7] Ozkan Y,Yardim-Akaydin S,Firat H,et al. Usefulness of homocysteine as a cancer marker:total thiol compounds and folate levels in untreated lung cancer patients[J].Anticancer Res,2007,27(2):1185-1189.[8] 魏 凯,黄毅超. 血浆同型半胱氨酸叶酸和维生素B12 水平与非小细胞肺癌的关系[J]. 国际检验医学杂志,2012,33 (6):699-701.[9] 王凌云,刘小芳,杜 涛,等.恶性肿瘤血清叶酸、维生素B12 水平测定的临床意义[J]. 重庆医学,2013,42(16):1870-1871.[10] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616.[11] Cakal B, Cakal E, Demirbas B, et al. Homocysteine and fi brinogen changes with L-thyroxine in subclinical hypothyroid patients[J].J Korean Med Sci, 2007,22(3):431-435.[12] Turhan S, Sezer S, Erden G, et al. Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism [J]. Ann Saudi Med,2008,28(2):96-101.[13] Blumenschein GR Jr,Paulus R,Curran WJ. Phase Ⅱ study of cetuximab in combination with chemoradiation in patients with stage ⅢA/B non-small-cell lung cancer: RTOG 0324[J].J Clin Oncol,2011,29(17):2312-2318.[14] Lin J, Lee IM, Song Y,et al.Plasma homocysteine and cysteine and risk of breast cancer in women[J]. Cancer Res, 2010,70(6):2397-2405.[15] Mandalà M, Barni S, Prins M, et al.Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial[J].Ann Oncol,2010,21(4):871-876.[16] 黄 慧. 恶性肿瘤患者血清同型半胱氨酸的变化[J].中国卫生检验杂志,2012,22(5):1116-1119.[17] 于 平,孙 静,白 莹,等. 非小细胞肺癌血清同型半胱氨酸水平的变化[J].中国医疗前言,2012,7(23) :54.[18] Shen H,Wei O,Pillow PC,et al. Dietary folate in take and lung cancer riskin former smokers:a case-control analysis[J].Cancer Epidem Biomar,2003,12(10):980-986.[19] Wasson GR, McGlynn AP, McNulty H,et al.Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation[J].J Nutr,2006,136(11):2748-2753.[20] 陈 萍.中西医结合治疗晚期非小细胞肺癌[J].长春中医药大学学报,2013,29(5):792-793.[21] 王 艳,焦丽丽.血清CEA/CA199对非小细胞肺癌临床预测价值研究[J].中国实用内科杂志,2013,33(增2):7-8.[22] 马进元,于 鹏,祝毓琳,等.晚期或转移性非小细胞肺癌全身治疗进展[J].中国实用内科杂志,2013,33(增1):164-166. |